TUhjnbcbe - 2021/8/19 3:15:00
TODAY今日发布JCardiovascMagnResonDec01,:21(1)今日发布01篇（共计46篇）BMCCardiovascDisordDec01,:19(1)今日发布01篇（共计篇）CardiovascDiabetolDec01,:18(1)今日发布01篇（共计97篇）ClinHypertensDec01,:25(1)今日发布02篇（共计15篇）IntJEmergMedDec01,:12(1)今日发布01篇（共计18篇）JAHAAug06,:8(15)今日发布13篇（共计48篇）CircHeartFailAug01,:12(8)今日发布04篇（共计05篇）CircCardiovascIntervAug01,:12(8)今日发布02篇（共计05篇）CircCardiovascImagingAug01,:12(8)今日发布03篇（共计08篇）JINTMEDRESEarlyRecent,July31,今日发布09篇ClinResCardiolEarlyRecent,July31,今日发布01篇JEchocardiogrEarlyRecent,July31,今日发布01篇TheJournalofVascularAccessEarlyRecent,July31,今日发布03篇PerfusionEarlyRecent,July31,今日发布02篇PhlebologyEarlyRecent,July31,今日发布01篇JournalofDiagnosticMedicalSonographyEarlyRecent,July31,今日发布01篇JENDOVASCTHEREarlyRecent,July31,今日发布06篇JAMAEarlyRecent,July31,今日发布02篇JAMACardiologyEarlyRecent,July31,今日发布08篇JINTMEDRESEarlyRecent,Aug01,今日发布02篇TheJournalofVascularAccessEarlyRecent,Aug01,今日发布01篇PerfusionEarlyRecent,Aug01,今日发布01篇StrokeEarlyRecent,Aug01,今日发布05篇EURHEARTJAug01,:40(29)今日发布18篇ATVBEarlyRecent,Aug01,今日发布03篇CirculationResearchEarlyRecent,Aug01,今日发布02篇RECOMMEND推荐阅读01真实世界中亚洲人群非瓣膜性房颤新型口服抗凝剂的间接比较：网络荟萃分析BMCCardiovascDisordResearcharticleJianchaoZhang,JunnanTang,etc.17小时前等11用户推荐阅读本文BackgroundThedevelopmentofnoveloralanticoagulants(NOACs)haschangedthelandscapeofnon-valvularatrialfibrillation(NVAF)management.Inthisstudy,theeffectivenessandthesafetyofseveralNOACswereevaluatedinareal-worldsettingamongAsianpatientswithNVAF.新型口服抗凝剂（NOAC）的发展改变了非瓣膜性房颤（NVAF）治疗的前景。在本研究中，我们在一个真实环境中评估了亚洲非瓣膜性房颤患者应用几种NOACs的有效性和安全性。MethodsTheliteraturesearchwasconductedcrossingdifferentdatabasesincludingEmbase,MEDLINE,andtheCochraneLibraryfrominceptionthroughMarch1,,forstudieswhichincludedreal-worldperspectives